{"url_path":"/sec/rfl/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits, Financial Statement Schedules.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-11","source_url":"https://www.sec.gov/Archives/edgar/data/1713863/0001213900-26-067560-index.html","accession_number":"0001213900-26-067560","cik":"0001713863","ticker":"RFL","issuer_name":"Rafael Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1713863/0001213900-26-067560-index.html","primary_entity_key":"0001713863","primary_entity_name":"Rafael Holdings, Inc."},"word_count":2066,"has_tables":true,"body_markdown":"**Item 6. Exhibits, Financial Statement Schedules.**\n\n** **\n\n**Exhibit\nNumber**\n \n**Description**\n\n \n \n \n\n31.1*\n \n[Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ea029331201ex31-1.htm)\n\n \n \n \n\n31.2*\n \n[Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ea029331201ex31-2.htm)\n\n \n \n \n\n32.1*\n \n[Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ea029331201ex32-1.htm)\n\n \n \n \n\n32.2*\n \n[Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ea029331201ex32-2.htm)\n\n \n \n \n\n101.INS*\n \nInline XBRL Instance Document\n\n \n \n \n\n101.SCH*\n \nInline XBRL Taxonomy Extension Schema Document\n\n \n \n \n\n101.CAL*\n \nInline XBRL Taxonomy Extension Calculation Linkbase Document\n\n \n \n \n\n101.DEF*\n \nInline XBRL Taxonomy Extension Definition Linkbase Document\n\n \n \n \n\n101.LAB*\n \nInline XBRL Taxonomy Extension Label Linkbase Document\n\n \n \n \n\n101.PRE*\n \nInline XBRL Taxonomy Extension Presentation Linkbase Document\n\n \n \n \n\n104*\n \nCover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).\n\n \n\n*Filed or furnished herewith.\n\n \n\n50\n\n \n\n**Signatures**\n\n \n\nPursuant to the requirements of Section 13 or\n15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Quarterly Report on Form 10-Q to be signed on its behalf\nby the undersigned, thereunto duly authorized.\n\n \n\nDate: June 11, 2026\n**Rafael Holdings, Inc.**\n\n \n \n \n\n \nBy:\n/s/ Howard Jonas\n\n \n \n**Howard Jonas**\n\n \n \n**Chief Executive Officer**\n\n \n \n \n\n \nBy:\n/s/ David Polinsky\n\n \n \n**David Polinsky**\n\n \n \n**Chief Financial Officer**\n\n \n\n51\n\n \n\n0.26\n\nhttp://fasb.org/srt/2026#ChiefFinancialOfficerMember\n\n0001713863\nfalse\nQ3\n--07-31\n\n0001713863\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nus-gaap:CommonClassAMember\n\n2026-06-09\n\n0001713863\n\nus-gaap:CommonClassBMember\n\n2026-06-09\n\n0001713863\n\n2026-04-30\n\n0001713863\n\n2025-07-31\n\n0001713863\n\nus-gaap:RelatedPartyMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:RelatedPartyMember\n\n2025-07-31\n\n0001713863\n\nus-gaap:CommonClassAMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:CommonClassAMember\n\n2025-07-31\n\n0001713863\n\nus-gaap:CommonClassBMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:CommonClassBMember\n\n2025-07-31\n\n0001713863\n\nrfl:ClassBTreasuryStockMember\n\n2026-04-30\n\n0001713863\n\nrfl:ClassBTreasuryStockMember\n\n2025-07-31\n\n0001713863\n\nrfl:InfusionTechnologyMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:InfusionTechnologyMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:InfusionTechnologyMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:InfusionTechnologyMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:RentalThirdPartyMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:RentalThirdPartyMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:RentalThirdPartyMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:RentalThirdPartyMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:RentalRelatedPartyMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:RentalRelatedPartyMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:RentalRelatedPartyMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:RentalRelatedPartyMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:ProductRevenueMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:ProductRevenueMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:ProductRevenueMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:ProductRevenueMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\n2026-02-01\n2026-04-30\n\n0001713863\n\n2025-02-01\n2025-04-30\n\n0001713863\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:InfusionTechnologyRevenueMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:InfusionTechnologyRevenueMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:InfusionTechnologyRevenueMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:InfusionTechnologyRevenueMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nus-gaap:CommonClassAMember\nus-gaap:CommonStockMember\n\n2026-01-31\n\n0001713863\n\nus-gaap:CommonClassBMember\nus-gaap:CommonStockMember\n\n2026-01-31\n\n0001713863\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-01-31\n\n0001713863\n\nus-gaap:RetainedEarningsMember\n\n2026-01-31\n\n0001713863\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2026-01-31\n\n0001713863\n\nus-gaap:NoncontrollingInterestMember\n\n2026-01-31\n\n0001713863\n\nus-gaap:CommonClassBMember\nus-gaap:TreasuryStockCommonMember\n\n2026-01-31\n\n0001713863\n\n2026-01-31\n\n0001713863\n\nus-gaap:CommonClassAMember\nus-gaap:CommonStockMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nus-gaap:CommonClassBMember\nus-gaap:CommonStockMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nus-gaap:RetainedEarningsMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nus-gaap:NoncontrollingInterestMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nus-gaap:CommonClassBMember\nus-gaap:TreasuryStockCommonMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nus-gaap:CommonClassAMember\nus-gaap:CommonStockMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:CommonClassBMember\nus-gaap:CommonStockMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:RetainedEarningsMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:NoncontrollingInterestMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:CommonClassBMember\nus-gaap:TreasuryStockCommonMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:CommonClassAMember\nus-gaap:CommonStockMember\n\n2025-07-31\n\n0001713863\n\nus-gaap:CommonClassBMember\nus-gaap:CommonStockMember\n\n2025-07-31\n\n0001713863\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-07-31\n\n0001713863\n\nus-gaap:RetainedEarningsMember\n\n2025-07-31\n\n0001713863\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2025-07-31\n\n0001713863\n\nus-gaap:NoncontrollingInterestMember\n\n2025-07-31\n\n0001713863\n\nus-gaap:CommonClassBMember\nus-gaap:TreasuryStockCommonMember\n\n2025-07-31\n\n0001713863\n\nus-gaap:CommonClassAMember\nus-gaap:CommonStockMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nus-gaap:CommonClassBMember\nus-gaap:CommonStockMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nus-gaap:RetainedEarningsMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nus-gaap:NoncontrollingInterestMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nus-gaap:CommonClassBMember\nus-gaap:TreasuryStockCommonMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nus-gaap:CommonClassAMember\nus-gaap:CommonStockMember\n\n2025-01-31\n\n0001713863\n\nus-gaap:CommonClassBMember\nus-gaap:CommonStockMember\n\n2025-01-31\n\n0001713863\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-01-31\n\n0001713863\n\nus-gaap:RetainedEarningsMember\n\n2025-01-31\n\n0001713863\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2025-01-31\n\n0001713863\n\nus-gaap:NoncontrollingInterestMember\n\n2025-01-31\n\n0001713863\n\nus-gaap:CommonClassBMember\nus-gaap:TreasuryStockCommonMember\n\n2025-01-31\n\n0001713863\n\n2025-01-31\n\n0001713863\n\nus-gaap:CommonClassAMember\nus-gaap:CommonStockMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nus-gaap:CommonClassBMember\nus-gaap:CommonStockMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nus-gaap:RetainedEarningsMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nus-gaap:NoncontrollingInterestMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nus-gaap:CommonClassBMember\nus-gaap:TreasuryStockCommonMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nus-gaap:CommonClassAMember\nus-gaap:CommonStockMember\n\n2025-04-30\n\n0001713863\n\nus-gaap:CommonClassBMember\nus-gaap:CommonStockMember\n\n2025-04-30\n\n0001713863\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-04-30\n\n0001713863\n\nus-gaap:RetainedEarningsMember\n\n2025-04-30\n\n0001713863\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2025-04-30\n\n0001713863\n\nus-gaap:NoncontrollingInterestMember\n\n2025-04-30\n\n0001713863\n\nus-gaap:CommonClassBMember\nus-gaap:TreasuryStockCommonMember\n\n2025-04-30\n\n0001713863\n\n2025-04-30\n\n0001713863\n\nus-gaap:CommonClassAMember\nus-gaap:CommonStockMember\n\n2024-07-31\n\n0001713863\n\nus-gaap:CommonClassBMember\nus-gaap:CommonStockMember\n\n2024-07-31\n\n0001713863\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2024-07-31\n\n0001713863\n\nus-gaap:RetainedEarningsMember\n\n2024-07-31\n\n0001713863\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2024-07-31\n\n0001713863\n\nus-gaap:NoncontrollingInterestMember\n\n2024-07-31\n\n0001713863\n\nus-gaap:CommonClassBMember\nus-gaap:TreasuryStockCommonMember\n\n2024-07-31\n\n0001713863\n\n2024-07-31\n\n0001713863\n\nus-gaap:CommonClassAMember\nus-gaap:CommonStockMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nus-gaap:CommonClassBMember\nus-gaap:CommonStockMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nus-gaap:RetainedEarningsMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nus-gaap:NoncontrollingInterestMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nus-gaap:CommonClassBMember\nus-gaap:TreasuryStockCommonMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:LipomedixPharmaceuticalsLtdMember\n\n2026-04-30\n\n0001713863\n\n2024-03-13\n2024-03-13\n\n0001713863\n\nrfl:RafaelMedicalDevicesIncMember\n\n2023-08-31\n\n0001713863\n\n2023-08-31\n\n0001713863\n\n2025-02-28\n\n0001713863\n\nrfl:RafaelMedicalDevicesIncMember\n\n2025-02-28\n\n0001713863\n\nrfl:CSPharmaHoldingsLLCMember\n\n2026-04-30\n\n0001713863\n\nrfl:PharmaHoldingsLLCMember\n\n2026-04-30\n\n0001713863\n\nrfl:CSPharmaHoldingsLLCOneMember\n\n2026-04-30\n\n0001713863\n\nrfl:PharmaHoldingsLLCMember\nus-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember\n\n2026-04-30\n\n0001713863\n\nrfl:BroadAtlanticAssociatesLLCMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:IDTREHoldingsLtdMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:RafaelRealtyHoldingsIncMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:BarerInstituteIncMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:HillviewAvenueRealtyJVMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:HillviewAvenueRealtyLLCMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:RafaelMedicalDevicesLLCMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:FarberPartnersLLCMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:PharmaHoldingsLLCMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:LipoMedixPharmaceuticalsLtdMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:AltiraCapitalConsultingLLCMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:CSPharmaHoldingsLLCMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:DayThreeLabsIncMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:CornerstonePharmaceuticalsMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:RPFinanceLLCMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:CycloTherapeuticsLLCMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nus-gaap:AccountsReceivableMember\nus-gaap:CustomerConcentrationRiskMember\nrfl:OneThirdPartyCustomerMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nus-gaap:AccountsReceivableMember\nus-gaap:CustomerConcentrationRiskMember\nrfl:OneRelatedPartyTenantMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:ThirdPartyCustomerOneMember\nus-gaap:AccountsReceivableMember\nus-gaap:CustomerConcentrationRiskMember\n\n2024-08-01\n2025-07-31\n\n0001713863\n\nrfl:ThirdPartyCustomerTwoMember\nus-gaap:AccountsReceivableMember\nus-gaap:CustomerConcentrationRiskMember\n\n2024-08-01\n2025-07-31\n\n0001713863\n\nus-gaap:AccountsReceivableMember\nus-gaap:CustomerConcentrationRiskMember\nrfl:OneRelatedPartyTenantMember\n\n2024-08-01\n2025-07-31\n\n0001713863\n\nus-gaap:SalesRevenueNetMember\nus-gaap:CustomerConcentrationRiskMember\nrfl:OneThirdPartyCustomerMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nus-gaap:SalesRevenueNetMember\nus-gaap:CustomerConcentrationRiskMember\nrfl:TwoThirdPartyCustomerMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nus-gaap:SalesRevenueNetMember\nus-gaap:CustomerConcentrationRiskMember\nrfl:OneThirdPartyTenantMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nus-gaap:SalesRevenueNetMember\nus-gaap:CustomerConcentrationRiskMember\nrfl:OneRelatedPartyTenantMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nus-gaap:SalesRevenueNetMember\nus-gaap:CustomerConcentrationRiskMember\nrfl:OneThirdPartyTenantMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nus-gaap:SalesRevenueNetMember\nus-gaap:CustomerConcentrationRiskMember\nrfl:OneRelatedPartyTenantMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nus-gaap:SalesRevenueNetMember\nus-gaap:CustomerConcentrationRiskMember\nrfl:OneThirdPartyCustomerMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nus-gaap:SalesRevenueNetMember\nus-gaap:CustomerConcentrationRiskMember\nrfl:OneThirdPartyTenantMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nus-gaap:SalesRevenueNetMember\nus-gaap:CustomerConcentrationRiskMember\nrfl:OneThirdPartyCustomerMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nus-gaap:SalesRevenueNetMember\nus-gaap:CustomerConcentrationRiskMember\nrfl:OneThirdPartyTenantMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nus-gaap:SalesRevenueNetMember\nus-gaap:CustomerConcentrationRiskMember\nrfl:OneRelatedPartyTenantMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nus-gaap:SalesRevenueNetMember\nus-gaap:CustomerConcentrationRiskMember\nrfl:OneThirdPartyCustomerMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\n2026-04-30\n2026-04-30\n\n0001713863\n\nus-gaap:IntellectualPropertyMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nus-gaap:IntellectualPropertyMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nus-gaap:IntellectualPropertyMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nus-gaap:IntellectualPropertyMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nus-gaap:BuildingAndBuildingImprovementsMember\n\n2026-04-30\n\n0001713863\n\nsrt:MinimumMember\nrfl:TenantImprovementsMember\n\n2026-04-30\n\n0001713863\n\nsrt:MaximumMember\nrfl:TenantImprovementsMember\n\n2026-04-30\n\n0001713863\n\nsrt:MinimumMember\nus-gaap:MachineryAndEquipmentMember\n\n2026-04-30\n\n0001713863\n\nsrt:MaximumMember\nus-gaap:MachineryAndEquipmentMember\n\n2026-04-30\n\n0001713863\n\nrfl:OtherprimarilyEquipmentAndFurnitureAndFixturesMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:CommonClassBMember\n\n2025-03-25\n2025-03-25\n\n0001713863\n\nrfl:CycloCommonStockMember\n\n2025-03-25\n2025-03-25\n\n0001713863\n\n2025-03-25\n2025-03-25\n\n0001713863\n\nrfl:RafaelMember\nus-gaap:CommonClassBMember\n\n2025-03-25\n2025-03-25\n\n0001713863\n\nus-gaap:WarrantMember\nrfl:RafaelsClassBCommonStockMember\n\n2025-03-25\n\n0001713863\n\nrfl:CycloConvertibleNotesMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:CycloMember\nrfl:CycloCommonStockMember\n\n2025-03-25\n\n0001713863\n\n2025-03-25\n\n0001713863\n\nrfl:CycloCommonStockMember\n\n2025-03-25\n\n0001713863\n\nus-gaap:CustomerRelationshipsMember\n\n2026-04-30\n\n0001713863\n\nrfl:CycloMember\n\n2026-04-30\n\n0001713863\n\nrfl:FairValueOfRafaelCommonSharesIssuedMember\nrfl:CycloMergerMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:FairValueOfRolloverOptionsMember\nrfl:CycloMergerMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:FairValueOfReplacementWarrantsMember\nrfl:CycloMergerMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:CashPaidToExtinguishWarrantsMember\nrfl:CycloMergerMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:FairValueOfTheCycloConvertibleNotesWhichWereForgivenMember\nrfl:CycloMergerMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:CycloMergerMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nus-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember\n\n2026-04-30\n\n0001713863\n\n2024-12-23\n2024-12-23\n\n0001713863\n\nrfl:CycloCommonStockMember\n\n2024-12-23\n\n0001713863\n\nrfl:RafaelHoldingsIncMember\n\n2024-12-23\n2024-12-23\n\n0001713863\n\nrfl:RafaelHoldingsIncMember\nrfl:InvestmentInCycloTherapeuticsIncMember\n\n2024-12-23\n\n0001713863\n\nrfl:RafaelHoldingsIncMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:InvestmentInCycloTherapeuticsIncMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:InvestmentInCycloTherapeuticsIncMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:CycloConvertibleNoteIMember\n\n2024-06-11\n\n0001713863\n\nrfl:CycloConvertibleNoteIMember\nrfl:NotePurchaseAgreementMember\n\n2024-06-11\n2024-06-11\n\n0001713863\n\nrfl:CycloConvertibleNoteIMember\n\n2024-06-11\n2024-06-11\n\n0001713863\n\nrfl:CycloConvertibleNoteIIMember\n\n2024-07-16\n\n0001713863\n\nrfl:CycloConvertibleNoteIIMember\nrfl:FirstAmendedAndRestatedNotePurchaseAgreementMember\n\n2024-07-16\n2024-07-16\n\n0001713863\n\nrfl:CycloConvertibleNoteIIMember\n\n2024-07-16\n2024-07-16\n\n0001713863\n\nrfl:CycloConvertibleNoteIIIMember\n\n2024-08-21\n\n0001713863\n\nrfl:CycloConvertibleNoteIIIMember\nrfl:SecondAmendedAndRestatedNotePurchaseAgreementMember\n\n2024-08-21\n2024-08-21\n\n0001713863\n\nrfl:CycloConvertibleNoteIIIMember\n\n2024-08-21\n2024-08-21\n\n0001713863\n\nrfl:CycloConvertibleNoteIVMember\n\n2024-09-09\n\n0001713863\n\nrfl:CycloConvertibleNoteIVMember\nrfl:ThirdAmendedAndRestatedNotePurchaseAgreementMember\n\n2024-09-09\n2024-09-09\n\n0001713863\n\nrfl:CycloConvertibleNoteIVMember\n\n2024-09-09\n2024-09-09\n\n0001713863\n\nrfl:CycloConvertibleNoteMember\n\n2024-09-09\n2024-09-09\n\n0001713863\n\nrfl:CycloConvertibleNoteVMember\n\n2024-10-08\n\n0001713863\n\nrfl:CycloConvertibleNoteVMember\nrfl:FourthAmendedAndRestatedNotePurchaseAgreementMember\n\n2024-10-08\n2024-10-08\n\n0001713863\n\nrfl:CycloConvertibleNoteVMember\n\n2024-10-08\n2024-10-08\n\n0001713863\n\nrfl:CycloConvertibleNoteMember\n\n2024-10-08\n2024-10-08\n\n0001713863\n\nrfl:CycloConvertibleNoteVIMember\n\n2024-11-07\n\n0001713863\n\nrfl:CycloConvertibleNoteVIMember\nrfl:FifthAmendedAndRestatedNotePurchaseAgreementMember\n\n2024-11-07\n2024-11-07\n\n0001713863\n\nrfl:CycloConvertibleNoteVIMember\n\n2024-11-07\n2024-11-07\n\n0001713863\n\nrfl:CycloConvertibleNoteMember\n\n2024-11-07\n2024-11-07\n\n0001713863\n\nrfl:CycloConvertibleNoteVIIMember\n\n2024-12-05\n\n0001713863\n\nrfl:CycloConvertibleNoteVIIMember\nrfl:SixthAmendedAndRestatedNotePurchaseAgreementMember\n\n2024-12-05\n2024-12-05\n\n0001713863\n\nrfl:CycloConvertibleNoteVIIMember\n\n2024-12-05\n2024-12-05\n\n0001713863\n\nrfl:CycloConvertibleNoteMember\n\n2024-12-05\n2024-12-05\n\n0001713863\n\nrfl:CycloConvertibleNoteMember\n\n2024-12-21\n2024-12-21\n\n0001713863\n\nrfl:CycloConvertibleNoteIIIMember\n\n2024-12-23\n\n0001713863\n\nrfl:CycloConvertibleNoteVIIIMember\n\n2025-01-03\n\n0001713863\n\nrfl:CycloConvertibleNoteVIIIMember\nrfl:SeventhAmendedAndRestatedNotePurchaseAgreementMember\n\n2025-01-03\n2025-01-03\n\n0001713863\n\nrfl:CycloConvertibleNoteVIIIMember\n\n2025-01-03\n2025-01-03\n\n0001713863\n\nrfl:CycloConvertibleNoteMember\n\n2025-01-03\n2025-01-03\n\n0001713863\n\nrfl:CycloConvertibleNoteIXMember\n\n2025-02-04\n\n0001713863\n\nrfl:CycloConvertibleNoteIXMember\n\n2025-02-04\n2025-02-04\n\n0001713863\n\nrfl:CycloConvertibleNoteMember\n\n2025-02-04\n2025-02-04\n\n0001713863\n\nrfl:CycloConvertibleNoteXMember\n\n2025-03-06\n\n0001713863\n\nrfl:CycloConvertibleNoteXMember\n\n2025-03-06\n2025-03-06\n\n0001713863\n\nrfl:CycloConvertibleNoteMember\n\n2025-03-06\n2025-03-06\n\n0001713863\n\nus-gaap:LineOfCreditMember\n\n2020-02-03\n\n0001713863\n\nus-gaap:LineOfCreditMember\n\n2020-02-03\n2020-02-03\n\n0001713863\n\nrfl:CornerstoneCommonStockMember\n\n2020-02-03\n2020-02-03\n\n0001713863\n\nrfl:RPFinanceMember\n\n2026-04-30\n\n0001713863\n\nrfl:HowardJonasMember\n\n2026-04-30\n\n0001713863\n\nrfl:OtherStockholdersOfCornerstoneMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:LineOfCreditMember\n\n2026-04-30\n\n0001713863\n\nrfl:RPFinanceMember\n\n2026-04-30\n\n0001713863\n\n2024-03-13\n\n0001713863\n\nrfl:RPFinanceMember\n\n2024-03-13\n2024-03-13\n\n0001713863\n\nus-gaap:CommonStockMember\n\n2024-03-13\n2024-03-13\n\n0001713863\n\nrfl:ConvertibleNotePayableMember\n\n2026-04-30\n\n0001713863\n\nrfl:ConvertibleNotePayableMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:SeriesCConvertibleNotesMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:SeriesCConvertibleNotesMember\nus-gaap:IPOMember\n\n2026-04-30\n\n0001713863\n\nrfl:SeriesCConvertibleNotesMember\nus-gaap:IPOMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:SeriesCConvertibleNotesMember\n\n2026-04-30\n\n0001713863\n\nrfl:CornerstoneMember\n\n2026-04-30\n\n0001713863\n\nrfl:SeriesCConvertibleNotesMember\nrfl:SettlementAgreementsMember\n\n2026-04-30\n\n0001713863\n\nrfl:SeriesCConvertibleNotesMember\nrfl:SettlementAgreementsMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:ConvertibleNotePayableMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:SeriesCConvertibleNotesMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:SeriesCConvertibleNotesMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:SeriesCConvertibleNotesMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\n2023-06-02\n2023-06-02\n\n0001713863\n\n2023-07-21\n2023-07-21\n\n0001713863\n\nrfl:CornerstoneMember\n\n2026-04-30\n\n0001713863\n\nrfl:CreditorPayableMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:CreditorPayableMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:SettlementAgreementsMember\n\n2026-01-30\n\n0001713863\n\n2026-01-30\n\n0001713863\n\n2024-03-08\n2024-03-08\n\n0001713863\n\nrfl:SteadyStateLLCMember\n\n2024-03-08\n2024-03-08\n\n0001713863\n\nrfl:SteadyStateLLCMember\n\n2024-03-08\n\n0001713863\n\n2024-03-08\n\n0001713863\n\nrfl:SoRSETechnologyCorporationMember\n\n2025-03-31\n2025-03-31\n\n0001713863\n\nrfl:SoRSETechnologyCorporationMember\n\n2025-03-31\n\n0001713863\n\nus-gaap:FairValueInputsLevel1Member\nus-gaap:ConvertibleDebtSecuritiesMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:FairValueInputsLevel2Member\nus-gaap:ConvertibleDebtSecuritiesMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:FairValueInputsLevel3Member\nus-gaap:ConvertibleDebtSecuritiesMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:ConvertibleDebtSecuritiesMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:FairValueInputsLevel1Member\n\n2026-04-30\n\n0001713863\n\nus-gaap:FairValueInputsLevel2Member\n\n2026-04-30\n\n0001713863\n\nus-gaap:FairValueInputsLevel3Member\n\n2026-04-30\n\n0001713863\n\nus-gaap:FairValueInputsLevel1Member\nus-gaap:ConvertibleDebtSecuritiesMember\n\n2025-07-31\n\n0001713863\n\nus-gaap:FairValueInputsLevel2Member\nus-gaap:ConvertibleDebtSecuritiesMember\n\n2025-07-31\n\n0001713863\n\nus-gaap:FairValueInputsLevel3Member\nus-gaap:ConvertibleDebtSecuritiesMember\n\n2025-07-31\n\n0001713863\n\nus-gaap:ConvertibleDebtSecuritiesMember\n\n2025-07-31\n\n0001713863\n\nus-gaap:FairValueInputsLevel1Member\n\n2025-07-31\n\n0001713863\n\nus-gaap:FairValueInputsLevel2Member\n\n2025-07-31\n\n0001713863\n\nus-gaap:FairValueInputsLevel3Member\n\n2025-07-31\n\n0001713863\n\nus-gaap:FairValueInputsLevel3Member\n\n2026-01-31\n\n0001713863\n\nus-gaap:FairValueInputsLevel3Member\n\n2025-01-31\n\n0001713863\n\nus-gaap:FairValueInputsLevel3Member\n\n2024-07-31\n\n0001713863\n\nus-gaap:FairValueInputsLevel3Member\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nus-gaap:FairValueInputsLevel3Member\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nus-gaap:FairValueInputsLevel3Member\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nus-gaap:FairValueInputsLevel3Member\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nus-gaap:FairValueInputsLevel3Member\n\n2025-04-30\n\n0001713863\n\nrfl:ThirdPartyMember\n\n2026-04-30\n\n0001713863\n\nrfl:ThirdPartyMember\n\n2025-07-31\n\n0001713863\n\nus-gaap:PropertyPlantAndEquipmentMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nus-gaap:PropertyPlantAndEquipmentMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nus-gaap:PropertyPlantAndEquipmentMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nus-gaap:PropertyPlantAndEquipmentMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nus-gaap:BuildingAndBuildingImprovementsMember\n\n2025-07-31\n\n0001713863\n\nus-gaap:MachineryAndEquipmentMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:MachineryAndEquipmentMember\n\n2025-07-31\n\n0001713863\n\nsrt:OtherPropertyMember\n\n2026-04-30\n\n0001713863\n\nsrt:OtherPropertyMember\n\n2025-07-31\n\n0001713863\n\nrfl:InfusionTechnologySegmentMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nus-gaap:HealthCareMember\n\n2025-07-30\n\n0001713863\n\nus-gaap:RealEstateMember\n\n2025-07-30\n\n0001713863\n\nrfl:InfusionTechnologyMember\n\n2025-07-30\n\n0001713863\n\n2025-07-30\n\n0001713863\n\nus-gaap:HealthCareMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:RealEstateMember\n\n2026-04-30\n\n0001713863\n\nrfl:InfusionTechnologyMember\n\n2026-04-30\n\n0001713863\n\n2025-06-30\n\n0001713863\n\nus-gaap:CustomerRelationshipsMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:CustomerRelationshipsMember\n\n2025-07-31\n\n0001713863\n\nrfl:SharesIssuableUponExerciseOfStockOptionsMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:SharesIssuableUponExerciseOfStockOptionsMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:SharesIssuableUponExerciseOfStockOptionsMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:SharesIssuableUponExerciseOfStockOptionsMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:SharesIssuableUponVestingOfRestrictedStockMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:SharesIssuableUponVestingOfRestrictedStockMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:SharesIssuableUponVestingOfRestrictedStockMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:SharesIssuableUponVestingOfRestrictedStockMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:SharesIssuableUponExerciseOfWarrantsMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:SharesIssuableUponExerciseOfWarrantsMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:SharesIssuableUponExerciseOfWarrantsMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:SharesIssuableUponExerciseOfWarrantsMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\ncountry:IL\n\n2026-04-30\n\n0001713863\n\ncountry:IL\n\n2025-08-01\n2026-04-30\n\n0001713863\n\ncountry:IL\n\n2024-08-01\n2025-07-31\n\n0001713863\n\nus-gaap:CommonClassBMember\n\n2025-05-06\n2025-05-06\n\n0001713863\n\nus-gaap:CommonClassBMember\n\n2025-05-06\n\n0001713863\n\n2025-05-06\n2025-05-06\n\n0001713863\n\nrfl:MrJonasMember\nus-gaap:CommonClassBMember\n\n2025-05-06\n\n0001713863\n\nrfl:MrJonasMember\nus-gaap:CommonClassBMember\n\n2025-06-04\n2025-06-04\n\n0001713863\n\nus-gaap:CommonClassBMember\n\n2025-06-04\n2025-06-04\n\n0001713863\n\nrfl:MrJonasMember\nus-gaap:CommonClassAMember\n\n2026-04-30\n\n0001713863\n\nrfl:MrJonasMember\nus-gaap:CommonClassBMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:CommonClassBMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\n2025-09-21\n\n0001713863\n\nus-gaap:PreferredStockMember\n\n2025-09-21\n\n0001713863\n\n2025-09-21\n2025-09-21\n\n0001713863\n\nus-gaap:WarrantMember\nus-gaap:PreferredStockMember\n\n2025-09-21\n\n0001713863\n\nrfl:NINAMedicalLtdMember\nus-gaap:PreferredStockMember\n\n2025-09-21\n\n0001713863\n\n2025-12-25\n\n0001713863\n\n2025-12-25\n2025-12-25\n\n0001713863\n\nrfl:ProductRevenueMember\nrfl:HealthcareOneMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:ProductRevenueMember\nrfl:InfusionTechnologyMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:ProductRevenueMember\nrfl:RealEstateOneMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:RentalThirdPartyMember\nrfl:HealthcareOneMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:RentalThirdPartyMember\nrfl:InfusionTechnologyMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:RentalThirdPartyMember\nrfl:RealEstateOneMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:RentalRelatedPartyMember\nrfl:HealthcareOneMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:RentalRelatedPartyMember\nrfl:InfusionTechnologyMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:RentalRelatedPartyMember\nrfl:RealEstateOneMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:CostOfProductRevenueMember\nrfl:HealthcareOneMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:CostOfProductRevenueMember\nrfl:InfusionTechnologyMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:CostOfProductRevenueMember\nrfl:RealEstateOneMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:CostOfProductRevenueMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:HealthcareOneMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:InfusionTechnologyMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:RealEstateOneMember\n\n2026-02-01\n2026-04-30\n\n0001713863\n\nrfl:ProductRevenueMember\nrfl:HealthcareOneMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:ProductRevenueMember\nrfl:InfusionTechnologyMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:ProductRevenueMember\nrfl:RealEstateOneMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:RentalThirdPartyMember\nrfl:HealthcareOneMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:RentalThirdPartyMember\nrfl:InfusionTechnologyMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:RentalThirdPartyMember\nrfl:RealEstateOneMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:RentalRelatedPartyMember\nrfl:HealthcareOneMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:RentalRelatedPartyMember\nrfl:InfusionTechnologyMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:RentalRelatedPartyMember\nrfl:RealEstateOneMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:CostOfProductRevenueMember\nrfl:HealthcareOneMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:CostOfProductRevenueMember\nrfl:InfusionTechnologyMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:CostOfProductRevenueMember\nrfl:RealEstateOneMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:CostOfProductRevenueMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:HealthcareOneMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:InfusionTechnologyMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:RealEstateOneMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:InfusionsTechnologyRevenueMember\nrfl:HealthcareOneMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:InfusionsTechnologyRevenueMember\nrfl:InfusionTechnologyMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:InfusionsTechnologyRevenueMember\nrfl:RealEstateOneMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:InfusionsTechnologyRevenueMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:ProductRevenueMember\nrfl:HealthcareOneMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:ProductRevenueMember\nrfl:InfusionTechnologyMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:ProductRevenueMember\nrfl:RealEstateOneMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:RentalThirdPartyMember\nrfl:HealthcareOneMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:RentalThirdPartyMember\nrfl:InfusionTechnologyMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:RentalThirdPartyMember\nrfl:RealEstateOneMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:RentalRelatedPartyMember\nrfl:HealthcareOneMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:RentalRelatedPartyMember\nrfl:InfusionTechnologyMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:RentalRelatedPartyMember\nrfl:RealEstateOneMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:CostOfInfusionTechnologyRevenueMember\nrfl:HealthcareOneMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:CostOfInfusionTechnologyRevenueMember\nrfl:InfusionTechnologyMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:CostOfInfusionTechnologyRevenueMember\nrfl:RealEstateOneMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:CostOfInfusionTechnologyRevenueMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:CostOfProductRevenueMember\nrfl:HealthcareOneMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:CostOfProductRevenueMember\nrfl:InfusionTechnologyMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:CostOfProductRevenueMember\nrfl:RealEstateOneMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:CostOfProductRevenueMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:HealthcareOneMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:InfusionTechnologyMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:RealEstateOneMember\n\n2025-02-01\n2025-04-30\n\n0001713863\n\nrfl:ProductRevenueMember\nrfl:HealthcareOneMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:ProductRevenueMember\nrfl:InfusionTechnologyMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:ProductRevenueMember\nrfl:RealEstateOneMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:InfusionsTechnologyRevenueMember\nrfl:HealthcareOneMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:InfusionsTechnologyRevenueMember\nrfl:InfusionTechnologyMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:InfusionsTechnologyRevenueMember\nrfl:RealEstateOneMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:InfusionsTechnologyRevenueMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:RentalThirdPartyMember\nrfl:HealthcareOneMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:RentalThirdPartyMember\nrfl:InfusionTechnologyMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:RentalThirdPartyMember\nrfl:RealEstateOneMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:RentalRelatedPartyMember\nrfl:HealthcareOneMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:RentalRelatedPartyMember\nrfl:InfusionTechnologyMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:RentalRelatedPartyMember\nrfl:RealEstateOneMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:CostOfInfusionTechnologyRevenueMember\nrfl:HealthcareOneMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:CostOfInfusionTechnologyRevenueMember\nrfl:InfusionTechnologyMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:CostOfInfusionTechnologyRevenueMember\nrfl:RealEstateOneMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:CostOfInfusionTechnologyRevenueMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:CostOfProductRevenueMember\nrfl:HealthcareOneMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:CostOfProductRevenueMember\nrfl:InfusionTechnologyMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:CostOfProductRevenueMember\nrfl:RealEstateOneMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:CostOfProductRevenueMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:HealthcareOneMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:InfusionTechnologyMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\nrfl:RealEstateOneMember\n\n2024-08-01\n2025-04-30\n\n0001713863\n\ncountry:US\n\n2026-04-30\n\n0001713863\n\ncountry:US\n\n2025-07-31\n\n0001713863\n\ncountry:IL\n\n2025-07-31\n\n0001713863\n\nus-gaap:LicenseMember\nsrt:MinimumMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nus-gaap:LicenseMember\nsrt:MaximumMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\ncountry:US\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nus-gaap:NonUsMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:ProductDevelopmentMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:CommercialsMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\n2017-05-01\n2017-05-31\n\n0001713863\n\nus-gaap:LicenseAgreementTermsMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:FifteenthAnniversaryMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\n2010-01-01\n2010-12-31\n\n0001713863\n\nrfl:DrGoldbergMember\n\n2025-08-04\n2025-08-04\n\n0001713863\n\n2025-08-12\n2025-08-12\n\n0001713863\n\nrfl:DrGoldbergMember\n\n2025-05-01\n2025-07-31\n\n0001713863\n\n2025-07-31\n2025-07-31\n\n0001713863\n\nrfl:PlanMember\nus-gaap:CommonClassBMember\n\n2022-01-19\n\n0001713863\n\nrfl:PlanMember\nus-gaap:CommonClassBMember\n\n2022-11-28\n\n0001713863\n\nrfl:PlanMember\nus-gaap:CommonClassBMember\n\n2025-01-13\n\n0001713863\n\nrfl:PlanMember\nus-gaap:CommonClassBMember\n\n2026-01-08\n\n0001713863\n\nrfl:PlanMember\nus-gaap:CommonClassBMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:PlanMember\n\n2026-04-30\n\n0001713863\n\nrfl:StockOptionsMember\n\n2026-04-30\n\n0001713863\n\nrfl:RMD2022PlanMember\n\n2026-04-30\n2026-04-30\n\n0001713863\n\nrfl:RMD2023PlanMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:RMD2023PlanMember\n\n2026-04-30\n\n0001713863\n\nrfl:RafaelMedicalDevicesLLCMember\n\n2026-04-30\n\n0001713863\n\nrfl:RafaelMedicalDevicesLLCMember\n\n2026-04-30\n2026-04-30\n\n0001713863\n\nrfl:CornerstoneCommonOptionsMember\n\n2026-04-30\n2026-04-30\n\n0001713863\n\nrfl:CornerstoneCommonOptionsMember\n\n2026-04-30\n\n0001713863\n\nrfl:ClassAOptionMember\n\n2026-04-30\n\n0001713863\n\nrfl:ClassBOptionMember\n\n2026-04-30\n\n0001713863\n\nrfl:CornerstoneCommonOptionsMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nsrt:BoardOfDirectorsChairmanMember\nus-gaap:RestrictedStockMember\n\n2025-01-06\n2025-01-06\n\n0001713863\n\nrfl:EmployeesAndConsultantsMember\nus-gaap:RestrictedStockMember\n\n2025-01-13\n2025-01-13\n\n0001713863\n\nus-gaap:RestrictedStockMember\nrfl:JonasOfferingMember\n\n2025-06-13\n2025-06-13\n\n0001713863\n\nus-gaap:RestrictedStockMember\nrfl:JohnGoldbergMember\n\n2025-09-02\n2025-09-02\n\n0001713863\n\nrfl:EmployeesAndConsultantsMember\nus-gaap:RestrictedStockMember\n\n2026-01-13\n2026-01-13\n\n0001713863\n\nsrt:BoardOfDirectorsChairmanMember\nus-gaap:RestrictedStockMember\n\n2026-01-28\n2026-01-28\n\n0001713863\n\nus-gaap:RestrictedStockMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:RestrictedStockMember\n\n2026-04-30\n2026-04-30\n\n0001713863\n\nrfl:RafaelMedicalDevicesLLCMember\n\n2025-07-30\n\n0001713863\n\nrfl:RafaelMedicalDevicesLLCMember\n\n2025-07-31\n2025-07-31\n\n0001713863\n\nrfl:RafaelMedicalDevicesLLCMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:RafaelMedicalDevicesLLCMember\n\n2026-04-30\n\n0001713863\n\nrfl:ReplacementWarrantsIssuedAsPartOfTheCycloMergerOnMarch252025Member\n\n2026-04-30\n\n0001713863\n\nrfl:WarrantsExpiredMember\n\n2025-08-01\n2026-04-30\n\n0001713863\n\nrfl:WarrantsOutstandingJanuary312026Member\n\n2026-04-30\n\n0001713863\n\nrfl:August2020PIPEWarrantMember\n\n2026-04-30\n\n0001713863\n\nrfl:April2023PIPEWarrantsMember\n\n2026-04-30\n\n0001713863\n\nrfl:October2023WarrantExchangeMember\n\n2026-04-30\n\n0001713863\n\nus-gaap:RestrictedStockMember\n\n2025-07-31\n\n0001713863\n\nus-gaap:RestrictedStockMember\n\n2025-08-01\n2026-04-30\n\nxbrli:shares\n\niso4217:USD\n\niso4217:USD\n\nxbrli:shares\n\nxbrli:pure\n\nrfl:Ratio\n\nutr:sqft"}